25 Nov Pathway to Prevention: Study of the Development of Type 1 Diabetes
Pathway to Prevention screening is the first step for all TrialNet prevention studies. Screening is offered at no cost to eligible individuals to evaluate their personal risk of developing the disease.This unique screening can identify the early stages of type 1 diabetes (T1D) years before any symptoms appear. It also helps researchers learn more about how T1D develops and plan new studies exploring ways to prevent it.
-Relatives of people with T1D are 15 times more likely to develop the disease than the general population.
-Increased risk of developing T1D is linked to the presence of five diabetes-related autoantibodies, regardless if you have a relative or not.
-Breakthrough T1D, ADA and Endocrine Society now classify having two or more of these autoantibodies as early stage T1D.
Screening is free, quick, convenient and super important. Only a small blood sample is needed. TrialNet screening is available by appointment at one of our many locations. We also offer two options for test kits that can be mailed directly to you:
-In-home Test Kit: This free kit provides everything you need to collect a finger-stick blood sample from the safety of your home. You can ship it back free using FedEx contactless at home pick up.
-Lab Test Kit: You can take this free screening kit to any Quest Diagnostics or LabCorp lab for a blood draw.
Participant Eligibility
You qualify for free risk screening if you:
-Are between the ages of 2 and 45 years and have a parent, brother/sister, or child with T1D
-Are between the ages of 2 and 20 years and have an aunt/uncle, cousin, grandparent, niece/nephew, or half-brother/sister with T1D
-Have not been diagnosed with diabetes
OR
-Are between the ages of 2 and 45 years and have tested positive for at least one T1D related autoantibody outside of TrialNet
-Have not been diagnosed with diabetes
Contact
the BRI Outreach Team
(800) 888-4187
Additional Study Details
Full Study Title
Natural History Study of the Development of Type 1 Diabetes
Investigator(s)
Carla Greenbaum, MD
Accepts Healthy Volunteers?
Yes
Study Site(s)
Benaroya Research Institute
1201 Ninth Avenue
Seattle, Washington 98101
Interested?
Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.
